Condition: Opioid Use Disorder · Sponsor: NYU Langone Health
This application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Corrections (MCHOC) as pre-trial detainees will be randomized at admission on a 1:1 basis to be inducted onto extended-release buprenorphine (XRB) at the time of admission (experimental condition) or remain in SLB (E-TAU; all participants will also receive naloxone). The two approaches will be compared with regard to (1) the percentage of participants released from jail with at least 7 days of buprenorphine in their system, (2) percentage of participants continuing MOUD treatment in the community, and (3) infractions related to buprenorphine diversion.
This description comes directly from the study's public registry record.
David Farabee · 310-963-0009 · David.farabee@nyulagone.org
Always discuss trial participation with your own doctor first.
| Tufts University Health Sciences | Boston, Massachusetts, United States | Recruiting |
| Baystate Health | Springfield, Massachusetts, United States | Recruiting |
| Middlesex County House of Corrections | New Brunswick, New Jersey, United States | Recruiting |
| NYU Langone Health - 180 Madison Ave | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06051890